Share class: ChemoMetec A/S

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,402,479 16,753,103 ( 96.27 %) 0 96.27 %

Major shareholders: ChemoMetec A/S

NameEquities%Valuation
3.63 %
631,637 3.63 % 32 M kr
Carnegie Fonder AB
2.961 %
515,222 2.961 % 26 M kr
Joh. Berenberg, Gossler & Co. KG (Investment Management)
1.821 %
316,912 1.821 % 16 M kr
First Fondene AS
0.67 %
116,600 0.67 % 6 M kr
Teknik Innovation Norden Fonder AB
0.5746 %
100,000 0.5746 % 5 M kr
Origo Fonder AB
0.3915 %
68,128 0.3915 % 3 M kr
Thesis Unit Trust Management Ltd.
0.3448 %
60,000 0.3448 % 3 M kr
Fundamental Fondsmæglerselskab A/S
0.3417 %
59,468 0.3417 % 3 M kr
Lonvia Capital SASU
0.2367 %
41,199 0.2367 % 2 M kr
Schroder Investment Management (Europe) SA (Finland)
0.2126 %
37,000 0.2126 % 2 M kr
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional8.94%
Individuals3.69%
Unknown87.37%

Based on 1000 largest holdings

Geographical origin of shareholders

Sweden
4.32%
Individuals
3.69%
Germany
1.87%
United Kingdom
0.73%
Norway
0.68%
Finland
0.43%
Denmark
0.36%
France
0.24%
Luxembourg
0.13%
United States
0.07%
Switzerland
0.04%
Liechtenstein
0.02%
Ireland
0.01%
Canada
0.01%
Spain
0.01%

Based on 1000 largest holdings

Logo ChemoMetec A/S
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
Employees
172